Screener
Stryker SYK Orthopaedics: — Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Stryker in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Stryker’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 11:10 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000310764-26-000031
FAQ
- What is Stryker's orthopaedics: — net sales?
- Stryker (SYK) reported orthopaedics: — net sales of $2.81B in Q1 2026.
- How has Stryker's orthopaedics: — net sales changed year-over-year?
- Stryker's orthopaedics: — net sales increased by 0.1% year-over-year, from $2.81B to $2.81B.
- What is the long-term trend for Stryker's orthopaedics: — net sales?
- Over 4 years (2021 to 2025), Stryker's orthopaedics: — net sales has grown at a 7.0% compound annual growth rate (CAGR), from $7.57B to $9.92B.
- What does orthopaedics: — net sales mean?
- This metric represents the total revenue generated from the sale of orthopaedic and spine-related medical devices, including joint replacements and spinal implants. It serves as a primary indicator of market demand and competitive performance within the musculoskeletal healthcare sector. Growth in this segment reflects the company's ability to capture market share through product innovation and clinical adoption.
Ask your AI about Stryker's orthopaedics: — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude